Results 81 to 90 of about 6,369 (156)

Correction to: REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. [PDF]

JNCI Cancer Spectr
europepmc   +1 more source

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. [PDF]

JNCI Cancer Spectr
Ng TL, Greenstreet P, Stober C, Nicholls S, Shamess J, Mills N, Ibrahim M, Savard MF, Rushton M, Awan A, Sehdev S, Hilton J, Song X, Fallah P, Alqahtani N, Davoudpour D, Daigle K, MacDonald F, Vandermeer L, Taljaard M, Clemons M.   +20 more
europepmc   +1 more source

Beyond Neutropenic Fever: Severe Multiorgan Immune-Related Toxicity Induced by Pembrolizumab. [PDF]

Cureus
Anastácio M, Pina Cabral T, Roldão M, Salgadinho Machado A, Lynce A.   +4 more
europepmc   +1 more source

Filgrastim after autologous stem cell transplantation shortens time to neutrophil recovery and hospital stay. [PDF]

Ann Hematol
Oosterink KA, Dekker TJA, Tjon JML, Marijt WAF, Te Boome LCJ, Veelken H, von dem Borne PA, Halkes CJM.   +7 more
europepmc   +1 more source

Short and Long-Term Outcomes in Kidney Transplant Recipients with Neutropenia or Leukopenia Following CMV Prophylaxis. [PDF]

J Health Econ Outcomes Res
Turzhitsky V, Li Q, Ai L, Jootun M, Wang W, Beyer A, Moise P, Kolobova I.   +7 more
europepmc   +1 more source

The use of granulocyte colony-stimulating factors in the management of breast cancer patients. [PDF]

Front Oncol
Bałata A, Szombara E, Nowecki ZI, Pogoda K.   +3 more
europepmc   +1 more source

Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim. [PDF]

Transfusion
Heyn J, Bräuninger S, Becker P, Stoeckmann N, Seidl C, Howe S, Daubert S, Fürst D, Schrezenmeier H, Bonig H.   +9 more
europepmc   +1 more source

Factors influencing hospital length of stay in febrile neutropenia: A retrospective cohort study of Turkish patients with solid tumors. [PDF]

Medicine (Baltimore)
Cekin R, Senocak D, Cihan S.
europepmc   +1 more source

Rare Invasive Fusarium Sinusitis in a Transiently Immunosuppressed Patient. [PDF]

Cureus
Archibald VL, Meenrajan SR, Schain D, Tishena A, Lo MC.   +4 more
europepmc   +1 more source

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

JAMA Netw Open
Riegler JS, Kesselheim AS, Rome BN.
europepmc   +1 more source